Arcus Biosciences Statistics
Total Valuation
RCUS has a market cap or net worth of $1.35 billion. The enterprise value is $589.43 million.
| Market Cap | 1.35B |
| Enterprise Value | 589.43M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RCUS has 90.86 million shares outstanding. The number of shares has increased by 2.78% in one year.
| Shares Outstanding | 90.86M |
| Shares Change (YoY) | +2.78% |
| Shares Change (QoQ) | +0.80% |
| Owned by Insiders (%) | 41.17% |
| Owned by Institutions (%) | 59.83% |
| Float | 54.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.53 |
| Forward PS | 10.67 |
| PB Ratio | 2.92 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.52, with zero debt.
| Current Ratio | 4.52 |
| Quick Ratio | 4.33 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -57.20% and return on invested capital (ROIC) is -73.59%.
| Return on Equity (ROE) | -57.20% |
| Return on Assets (ROA) | -25.80% |
| Return on Capital (ROIC) | -73.59% |
| Revenue Per Employee | $202,773 |
| Profits Per Employee | -$532,062 |
| Employee Count | 577 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, RCUS has paid $6.00 million in taxes.
| Income Tax | 6.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.56% in the last 52 weeks. The beta is 0.85, so RCUS's price volatility has been lower than the market average.
| Beta (1Y) | 0.85 |
| 52-Week Price Change | -20.56% |
| 50-Day Moving Average | 17.49 |
| 200-Day Moving Average | 17.71 |
| Relative Strength Index (RSI) | 33.78 |
| Average Volume (30 Days) | 852,848 |
Short Selling Information
The latest short interest is 8.25 million, so 9.08% of the outstanding shares have been sold short.
| Short Interest | 8.25M |
| Short Previous Month | 7.68M |
| Short % of Shares Out | 9.08% |
| Short % of Float | 15.17% |
| Short Ratio (days to cover) | 10.54 |
Income Statement
In the last 12 months, RCUS had revenue of $117.00 million and -$307.00 million in losses. Loss per share was -$4.15.
| Revenue | 117.00M |
| Gross Profit | 117.00M |
| Operating Income | -340.00M |
| Pretax Income | -301.00M |
| Net Income | -307.00M |
| EBITDA | -285.00M |
| EBIT | -301.00M |
| Loss Per Share | -$4.15 |
Balance Sheet
The company has $759.00 million in cash and no debt, giving a net cash position of $759.00 million or $8.35 per share.
| Cash & Cash Equivalents | 759.00M |
| Total Debt | n/a |
| Net Cash | 759.00M |
| Net Cash Per Share | $8.35 |
| Equity / Book Value | 462.00M |
| Book Value Per Share | 5.08 |
| Working Capital | 647.00M |
Cash Flow
In the last 12 months, operating cash flow was -$306.00 million and capital expenditures -$24.00 million, giving a free cash flow of -$330.00 million.
| Operating Cash Flow | -306.00M |
| Capital Expenditures | -24.00M |
| Free Cash Flow | -330.00M |
| FCF Per Share | -$4.46 |
Margins
Gross margin is 100.00%, with operating and profit margins of -290.60% and -262.39%.
| Gross Margin | 100.00% |
| Operating Margin | -290.60% |
| Pretax Margin | -257.26% |
| Profit Margin | -262.39% |
| EBITDA Margin | -243.59% |
| EBIT Margin | -257.26% |
| FCF Margin | -282.05% |
Dividends & Yields
RCUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.78% |
| Shareholder Yield | -2.78% |
| Earnings Yield | -22.77% |
| FCF Yield | -24.47% |
Analyst Forecast
The average price target for RCUS is $41.78, which is 181.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.78 |
| Price Target Difference | 181.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 39.41% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RCUS has an Altman Z-Score of 0.1 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.1 |
| Piotroski F-Score | 2 |